Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR&Q Insurance Regulatory News (RQIH)

Share Price Information for R&Q Insurance (RQIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.338
Bid: 0.30
Ask: 0.39
Change: -1.5095 (-81.71%)
Spread: 0.09 (30.00%)
Open: 0.50
High: 0.60
Low: 0.30
Prev. Close: 1.8475
RQIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of sale of R&Q Managing Agency Limited

1 Dec 2017 07:00

RNS Number : 0654Y
Randall & Quilter Inv Hldgs Ltd
01 December 2017
 

Randall & Quilter Investment Holdings Ltd.

 

Completion of the sale of R&Q Managing Agency Limited to Coverys

 

1 December 2017

 

On 27 June 2017, R&Q announced the sale of its Lloyd's managing agency, R&Q Managing Agency Ltd ('RQMA') to Coverys, a leading provider of medical professional liability insurance based in Boston, Massachusetts, subject to regulatory change of control approval. We are now pleased to announce that all of the necessary approvals have been obtained and the transaction completed on 30th November 2017. RQMA will subsequently be renamed as Coverys Managing Agency Limited.

 

As previously announced, the sale proceeds to be received in cash are $22.6m, which, after costs and related incentive and other payments, will result in net proceeds to R&Q of £13.1m. This is expected to generate a gain of approximately £11.8m over the Group's carrying value of RQMA.

 

RQMA is currently the managing agent for three syndicates: Syndicate 1991 which writes niche SME property and casualty business with a capacity of circa £127m; Syndicate 3330 which provides reinsurance-to-close and other reinsurance solutions for legacy business within Lloyd's; and since, 27th October 2017, Syndicate 1110 the former ProSight syndicate which was placed into run-off in 2017. R&Q also acquired ProSight's corporate members on this date and so participates on 100% of Syndicate 1110's open years. R&Q has the benefit of substantial adverse development reinsurance from a ProSight group company.

 

RQMA also provides back office support to Syndicate 2088; the syndicate managed by XL Catlin and backed by China Re.

 

In addition, Coverys has gained in-principle approval from Lloyd's to establish Syndicate 1975 which will be managed by RQMA. Syndicate 1975 is expected to commence underwriting on 1 January 2018 and will write both med-mal insurance and healthcare reinsurance.

 

Ken Randall, R&Q chairman and CEO, commented: "We are pleased to have concluded this transaction with Coverys which is a key element of our strategy to focus on legacy acquisitions and the writing of quality program business, which is mostly reinsured to highly rated reinsurers.

 

We have already demonstrated how Coverys and R&Q are able to continue working together through the approval process of turnkey Syndicate 1975 and the ongoing management of the run-off Syndicate 1110. We look forward to continuing to build this relationship and exploring further opportunities to work together in the future. We remain an active participant as regards legacy portfolios at Lloyd's and have a pipeline of further opportunities which we hope enhance our collaboration with Coverys."

 

Gregg L Hanson, CEO and President of Coverys, said: "Through the acquisition, Coverys will inherit the continued responsibility to support the syndicates currently under management with RQMA. The acquisition additionally allows Coverys to assist new underwriting syndicates that seek to launch their business at Lloyd's, while also maintaining business operations for existing syndicates. We are excited to enter the London marketplace and will look to RQMA's industry knowledge and expertise to guide us in this prestigious market."

Ends

 

 

Enquiries to:

 

Randall & Quilter Investment Holdings Ltd.

www.rqih.com

Tom Booth

Tel: +1 441 247 8330

 

Numis Securities Limited (Nominated Adviser)

Stuart Skinner

Tel: 020 7260 1000

Charles Farquhar

Tel: 020 7260 1000

 

Shore Capital Stockbrokers Limited

Dru Danford / Stephane Auton

 

Tel: 020 7408 4090

FTI Consulting

Edward Berry/Tom Blackwell

 

 

Tel: 020 3727 1046

 

 

 

 

Notes to Editors:

 

About R&Q 

The overall mission of the Bermuda based Group is to:

· generate profits and capital extractions from expert management of legacy non-life insurance acquisitions/ reinsurances, including in Lloyd's; and 

 

· grow commission income from its licensed (and rated) carriers in the US and EU/UK, writing niche and profitable programme business, largely on behalf of highly rated reinsurers.

Our aim is to continue to grow sustainable profit streams to support our business model and increase book value and cash distributions to shareholders. 

The Group was founded by Ken Randall and Alan Quilter in 1991.

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAPFEDLFXFFF
Date   Source Headline
13th Jun 20247:35 amRNSUpdate on proposed sale of Accredited
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings
10th May 20232:30 pmRNSTR-1: Notification of major holdings
10th May 202311:26 amRNSTR-1: Notification of major holdings
4th Apr 20237:00 amRNSStrategic & Trading Update
31st Mar 20237:00 amRNSAppointment of Non-Executive Chairman
17th Mar 20237:00 amRNSCompletion of Tradesman Sale
3rd Mar 202312:16 pmRNSTR-1: Notification of major holdings
23rd Feb 20237:00 amRNSProgram Management Update and Sale of Tradesman
17th Jan 20237:00 amRNSProgram Management Update
12th Jan 20237:00 amRNSPDMR/Director Shareholding and Total Voting Rights
6th Jan 20237:00 amRNSJoint venture to acquire legacy liabilities
5th Dec 20227:00 amRNSLoss Portfolio Transfer
31st Oct 20227:00 amRNSQ3 2022 Program Management Update
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.